This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Oncology

EC approves brigatinib for ALK+ non-small cell lung cancer
EC approves brigatinib for ALK+ non-small cell lung cancer
Cryoablation shows promise in treating low-risk breast cancers
Cryoablation shows promise in treating low-risk breast cancers
Mogamulizumab receives positive opinion for mycosis fungoides and Sézary syndrome
Mogamulizumab receives positive opinion for mycosis fungoides and Sézary syndrome
NICE recommends Vyxeos in specific types of secondary AML
NICE recommends Vyxeos in specific types of secondary AML
Olarpip could provide effective treatment for brain tumours, charity reveals
Olarpip could provide effective treatment for brain tumours, charity reveals
BRCA testing – making treatment decisions today and planning for the future
BRCA testing – making treatment decisions today and planning for the future
Bowel cancer rates increasing across Europe
Bowel cancer rates increasing across Europe
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Drugs for treating breast cancer in women are effective and well tolerated in men
Drugs for treating breast cancer in women are effective and well tolerated in men
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Immunotherapy may become new first line treatment in some metastatic colorectal cancers


Popular articles

Study shows HIV vaccine ineffective
RSV vaccine meets primary endpoint in older adults
Yescarta approved by NICE for relapsed/remitted lymphomas
Single low-dose CT scan helps predict future lung cancer risk
Dupixent approved for severe atopic dermatitis in children from 6 months




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora